Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in Combination With Pembrolizumab in Adult Participants With Locally Advanced or Metastatic HER2-Expressing Cancers
Apply
VIR-5818 & Pembrolizumab
To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in Combination With Pembrolizumab in Adult Participants With Locally Advanced or Metastatic HER2-Expressing Cancers
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step